Results 211 to 220 of about 81,604 (317)

General trends in the calnexin-dependent expression and pharmacological rescue of clinical CFTR variants. [PDF]

open access: yesElife
Tedman A   +12 more
europepmc   +1 more source

Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D‐CFTR

open access: green, 2014
Zhe Xu   +7 more
openalex   +1 more source

Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a dismal prognosis, largely because of late‐stage diagnosis and therapeutic resistance. PDAC incidence has been rising, with modifiable and non‐modifiable risk factors contributing to disease development.
Alessandro Mannucci, Ajay Goel
wiley   +1 more source

L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators? [PDF]

open access: yesInt J Mol Sci
Kondratyeva E   +10 more
europepmc   +1 more source

GRASPing CFTR [PDF]

open access: yesNature Chemical Biology, 2011
openaire   +1 more source

In vivo conformational space and defects of misfolded CFTR variants by covalent protein painting. [PDF]

open access: yesNat Commun
Pankow S   +4 more
europepmc   +1 more source

Beyond F508del: equity as the next frontier in cystic fibrosis. [PDF]

open access: yesLancet Reg Health Am
Cohen RWF   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy